Array BioPharma, Inc. to Present at the Lazard Annual Healthcare and Jefferies and Co. 2012 Global Healthcare Conferences
Published: Nov 08, 2012
BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
Lazard Capital Markets 9th Annual Healthcare Conference
Tuesday, November 13, 2012
11:00 a.m. Eastern Time
The Pierre Hotel, New York, NY
Jefferies 2012 Global Healthcare Conference
Thursday, November 15, 2012
2:20 p.m. Greenwich Mean Time
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted smallmolecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two whollyowned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto
Array BioPharma Inc.
SOURCE Array BioPharma Inc.